Cardiomyopathy protection in Chagas Disease

作     者：Jorge E. Mitelman Luisa Gimenez 

作者机构：Instituto Centenario Buenos Aires Argentine Chagas Disease of the Inter-American Society of Cardiology Buenos Aires Argentine Department of Chagas the University Institute of Health Science Foundation H A Barcelo Buenos Aires Argentine Teodoro Alvarez Hospital Buenos Aires Argentine Cardiology in Northern Province of Buenos Aires Buenos Aires Argentine Chagas in the City of Buenos Aires Buenos Aires Argentine University Institute of Health Science Foundation H A Barcelo Buenos Aires Argentine 

出 版 物：《World Journal of Cardiovascular Diseases》 (心血管病（英文）)

年 卷 期：2013年第3卷第7期

页      面：442-447页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：Chagas Disease Chronic Period without Demonstrable Pathology Ex Indeterminate Phase Endothelial Dysfunction Cardiac Dysautonomia Simvastatin ACE (Angiotensin Converting Enzyme) Inhibitor Muscarinic Antibody 

摘      要：There is some published evidence suggesting micro vascular endothelial dysfunction and dysautonomia involvement in Chagas disease in association with cardiomyocyte changes favoring disease progression. The combined treatment between angiotensin converting enzyme (ACE) inhibitor drugs;Simvastatin, muscarinic antibody immunoadsorbent together with fungicidal drugs would open therapeutic possibilities in this disease.